• DOI:10.1038/ncponc0132
Corpus ID: 20464189

Drug Insight: new antiemetics in the management of chemotherapy-induced nausea and vomiting

@article{Oo2005DrugIN,
  title={Drug Insight: new antiemetics in the management of chemotherapy-induced nausea and vomiting},
  author={T. Oo and P. Hesketh},
  journal={Nature Clinical Practice Oncology},
  year={2005},
  volume={2},
  pages={196-201}
}

T. Oo, P. Hesketh

Published 2005

Medicine

Nature Clinical Practice Oncology

Nausea and vomiting remain among the most feared side effects of chemotherapy for cancer patients. Significant progress has been made in the last 15 years in developing more effective and better-tolerated measures to minimize chemotherapy-induced nausea and vomiting (CINV). During the 1990s, the selective 5-hydroxytryptamine receptor antagonists were first introduced for the treatment of CINV, and resulted in more effective and better tolerated treatment of CINV. Despite recent progress… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed